TPP decreases melanoma tumor growth rate when administered via hydrogel. by Kyle C. Kloepping (9928265)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

Increased oxidative stress, viral load and decreased survivability of N2a following RIG-I ablation. by Arshed Nazmi (215284)

“…<p>Flow cytometric analysis carried out from cells of all treatment groups to detect intracellular JEV antigen showed significant increase post RIG-I ablation when compared to only JEV-infected or JEV+ScMO groups. The mean fluorescence intensities obtained from each group are depicted in the figure. (1-Unstained, 2-Mock-infected; 3-JEV-infected, 4-JEV+Sc-MO, 5-JEV+rMO) (A). …”

Tranilast decreases OC formation induced by RANKL. by Tien Van Phan (583324)

Collagen V oral administration decreases inflammation and remodeling of synovial membrane in experimental arthritis - Fig 3 by Silvana Ramos Atayde (5571041)

“…Original magnification: A-H, 200×; I-L, 400×. Values are the means (±SEM) of 10 animals in each group. …”

<i>A</i>, HDACi-mediated decrease in CHK1 precedes apoptosis. by William Brazelle (358865)

Decrease of receptor detectibility following CRAD replication in a small fraction of cells. by Johan Rebetz (255622)

Chronic administration of propranolol decreases airway epithelial MUC5AC expression in rats exposed to CS. by Yujiao Zhou (573776)

<i>Slc8a1</i> silencing decreases Na⁺ influx and Ca²⁺ efflux. by Patrick Neubert (2092156)

CGRP decreases LPS-induced IL-1β mRNA levels. by Aichurek Soultanova (3219459)

Predicting alternans in the V_m-driven model during a progressive decrease of I_Ks conductance. by Mathieu Lemay (330649)

Neither imatinib nor nilotinib induce a decrease of LTC-IC frequency. by Ludovic Belle (293091)

Fig 5 - by Duyan Geng (12072181)

Cytochalasin D decreases pyroptosis in TLR ligand-activated Raw264.7 cells. by Peeraya Ekchariyawat (3911113)

RP loss results in a decrease of IRS1 and phosphorylated AKT substrates. by Harry F. Heijnen (569486)

NSAIDs decrease the viability of ovarian cancer cells in a dose-dependent manner. by Blanca L. Valle (406582)

Treatment with FTY720 induces a decrease in inactive (phosphorylated) SAMHD1. by Rachel S. Resop (9238645)

Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)